Literature DB >> 23152457

Maternal cocaine use during breastfeeding.

Alex M Cressman1, Gideon Koren, Anna Pupco, Eunji Kim, Shinya Ito, Pina Bozzo.   

Abstract

QUESTION: In my practice several patients have struggled with cocaine abuse during their pregnancies. One woman, now postpartum, wants to breastfeed her infant. Despite being abstinent for the final few months of her pregnancy, I am concerned about the potential adverse effects on her child if she happens to relapse. What is the current evidence about the risks of cocaine exposure during breastfeeding? ANSWER: Given the substantial benefits of breastfeeding for infant health and development, there is no reason for mothers who previously abused cocaine to avoid breastfeeding. It is important for the health care team to counsel patients both on the serious potential risks of cocaine exposure for babies and on the benefits of breastfeeding, to allow for an informed choice. Additionally, attempts should be made to estimate maternal commitment to breastfeeding and discontinuation of cocaine use, and to offer addiction counseling to mitigate the potential risks of infant cocaine exposure. It is paramount to minimize the risk to the infant, which would certainly include mothers ceasing use of cocaine while breastfeeding. For mothers who elect to breastfeed and use cocaine intermittently, breastfeeding should be delayed sufficiently after cocaine use to allow for drug elimination (approximately 24 hours).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152457      PMCID: PMC3498013     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  16 in total

1.  When a cocaine-using mother wishes to breastfeed: proposed guidelines.

Authors:  Moumita Sarkar; Josephine Djulus; Gideon Koren
Journal:  Ther Drug Monit       Date:  2005-02       Impact factor: 3.681

2.  Cocaine convulsions in a breast-feeding baby.

Authors:  N E Chaney; J Franke; W B Wadlington
Journal:  J Pediatr       Date:  1988-01       Impact factor: 4.406

3.  The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report.

Authors:  B M Lester; M ElSohly; L L Wright; V L Smeriglio; J Verter; C R Bauer; S Shankaran; H S Bada; H H Walls; M A Huestis; L P Finnegan; P L Maza
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

Review 4.  Breastfeeding and the use of human milk.

Authors: 
Journal:  Pediatrics       Date:  2012-02-27       Impact factor: 7.124

Review 5.  An overview of non-cardiac cocaine toxicity.

Authors:  Jonathan Glauser; John R Queen
Journal:  J Emerg Med       Date:  2007-01-22       Impact factor: 1.484

6.  Human milk, breastfeeding, and transmission of human immunodeficiency virus type 1 in the United States. American Academy of Pediatrics Committee on Pediatric AIDS.

Authors:  Jennifer S Read
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

7.  Cocaine intoxication in a breast-fed infant.

Authors:  I J Chasnoff; D E Lewis; L Squires
Journal:  Pediatrics       Date:  1987-12       Impact factor: 7.124

8.  Prevalence of fetal exposure to cocaine in Toronto, 1990-1991.

Authors:  R Forman; J Klein; J Barks; D Mehta; M Greenwald; T Einarson; G Koren
Journal:  Clin Invest Med       Date:  1994-06       Impact factor: 0.825

9.  Pharmacokinetics of cocaine: basic studies of route, dosage, pregnancy and lactation.

Authors:  R C Wiggins; C Rolsten; B Ruiz; C M Davis
Journal:  Neurotoxicology       Date:  1989       Impact factor: 4.294

10.  The routine analysis of breast milk for drugs of abuse in a clinical toxicology laboratory.

Authors:  P H Dickson; A Lind; P Studts; H C Nipper; M Makoid; D Therkildsen
Journal:  J Forensic Sci       Date:  1994-01       Impact factor: 1.832

View more
  1 in total

1.  A Retrospective Cohort Study Examining the Utility of Perinatal Urine Toxicology Testing to Guide Breastfeeding Initiation.

Authors:  Miriam Harris; Kathleen Joseph; Bettina Hoeppner; Elisha M Wachman; Jessica R Gray; Kelley Saia; Sarah Wakeman; Megan H Bair-Merritt; Davida M Schiff
Journal:  J Addict Med       Date:  2021 Jul-Aug 01       Impact factor: 3.702

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.